Trial
NCT00638820
Reduced Intensity AlloTransplant For Osteopetrosis
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
Osteopetrosis
Intervention
Stem Cell or Umbilical Cord Blood Transplantation
Why stopped
Excess toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28